Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes
CompletedOBSERVATIONAL
Enrollment
1,000
Participants
Timeline
Start Date
January 20, 2024
Primary Completion Date
July 29, 2025
Study Completion Date
July 29, 2025
Conditions
Type2diabetes
Trial Locations (1)
122001
Medanta Division of Endocrinology & Diabetes, Gurgaon
All Listed Sponsors
lead
Medanta, The Medicity, India
OTHER
NCT06289387 - Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes | Biotech Hunter | Biotech Hunter